Skip to main content
Clinical Trials/CTRI/2023/07/055312
CTRI/2023/07/055312RecruitingPhase 2

Study the effect of Panchtikta niruh basti in the management of sthool pramehi withspecial reference to diabetes mellitus (type-2) - Randomised controlled trial.

Dr. Tirth Mihir Shah0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • RECENTLY DIAGNOSED CASE OF TYPE -2 DM WITH
  • 1.Blood Sugar Levels Fasting 100 mg/dl – 126 mg/dl
  • Blood Sugar Levels PostPrandial 140 mg/dl -199 mg/dl.
  • 2.Glycosylated hemoglobin i.e. HbA1C - 5.7 – 6.4
  • 3.BMI > 25 ( overweight) [19]]
  • 4.Gender: Male & Female both
  • 5.Age - 30 to 60 years

Exclusion Criteria

  • TYPE-1 Diabetes Mellitus (IDDM) or patients who are currently on Insulin or any Oral Hypoglycemic Agents.
  • k/c/o ketoacidosis, diabetic coma, diabetic nephropathy ,
  • Uncontrolled Hypertension ,gangrene.

Investigators

Sponsor
Dr. Tirth Mihir Shah

Similar Trials